Absci Corporation has grown revenue −43% a year over three years and −22% a year over five. Revenue growth, 3-year annual rate: −43% (Biotechnology median +17%). Revenue growth, 5-year rate: −22%, growth has slowed since the five-year average. Years of annual history on file: 6, FY2020 to FY2025, as filed.

ABSIAbsci Corporation

Healthcare

$10.17+289% 1Y

$10.17

$2.3052 weeks$11.53

Is it growing?

Watch

Growth is fading: revenue shrinking (−62% year on year) and operating margin narrowing (−6004.9 points).

2 to watch, 1 without data

Revenue trend−62% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −22% a year.

Margin direction−6004.9 points operating

Trailing-twelve-month operating margin, -9460.3% now against -3455.5% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ABSI growing?

Absci Corporation has grown revenue −43% a year over three years and −22% a year over five.

−43%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −22%
Revenue growth, 5-year rate · −43% over three · growth has slowed since the five-year average
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›